Podcasts about Verve

One of the more recent tropes in pro wrestling is "Why am I so violent?", where a babyface wrestler will have a crisis of conscience about the level of violence they are dishing out against their opponent (and typically stare at their hands while doing so). It's meant to be this dramatic emotional arc, but more often it just makes the babyface look like an idiot and a coward for not wanting to hurt their opponent. On this episode, Andrew comes up with one of his delightfully devilish puns with a topic called "Why am I so violin?", in which he and first-time guest Hypnotoad (VOW Discord) play songs that have a string section instrument in them (violin, viola, cello, double bass). Artists played include Kansas, The Cranberries, Ben E. King, Dexys Midnight Runners, The Shirelles, Queensrÿche, The Verve, and many more. Don't stare at your hands too long, or else you might miss this episode!Theme song: "Hemispheres" by Silent PartnerBluesky: @MusicoftheMat / @justandrewAll VOW podcasts, articles, previews, and reviews: VoicesofWrestling.comJoin the VOW Discord to discuss Music of the Mat and other shows/topics: VoicesofWrestling.com/DiscordDonate to Music of the Mat and other VOW podcasts: VoicesofWrestling.com/DonateOur Sponsors:* Sign up for MyBookie today and use our code VOWNETWORK for access to MyBookie's one of a kind Bet Back Bonus! If your bet hits, you win. If it misses, you'll earn a 100% Refund of up to $500 in Free Play. It's win-win. Get in on the action now at https://www.mybookie.agAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

The podcast edition of Charlottesville Community Engagement marks the end of one week and the beginning of the next, and serves as a way to process and reset. The mission of this newsletter is to bring people stories about local and regional government and the audio version is a good way to hear some of the voices of decision-makers and those who speak up at meetings.Most of you are not listeners of the podcast but this is also a time for you to catch up on some of the stories. The links below go to Information Charlottesville, the archive for most of what goes out in the newsletter.If you learned something from the stories, please share them with other people you think might be interested.In this edition:* Charlottesville is on track to meet a 2021 spending goal for subsidized housing (read the story on C-Ville Weekly)* Lack of administrative capacity slowing Charlottesville's affordable housing progress (read the story)* Albemarle County Supervisors learned in early August that growth area master plans will no longer be updated in favor of “activity centers” and “multimodal transportation planning” (read the story)* The Charlottesville Albemarle Regional Transit Authority in late August took another look at a study intended to determine what route expansions should be selected to seek additional funding (read the story)* Albemarle Supervisors want a say in governance of actual transit decisions (read the story)Charlottesville Community Engagement is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.Sponsored message: Panorama Natural BurialAt Panorama Natural Burial, we believe caring for the deceased can be simple, meaningful, and deeply connected to the natural world. As a natural burial ground just outside Charlottesville, we offer families an alternative to traditional burial that honors both the people we love and the land that will carry them forward.Whether you are planning ahead, navigating a recent loss, or are just curious about natural burial, we welcome the conversation. We host regular tours and community events throughout the year. At Panorama we are building new ways of understanding death, land, ecology, ritual, memory, and community. We believe that building community around death care helps us all to live fuller lives. We are open to the public daily 9 a.m. to 7 p.m. Come visit!Thoughts at the end of #1127-A for paid subscribersFun fact: This is only the third edition of this newsletter to come out on September 19.* In 2022, I did a Week Ahead with previews about what was coming up that week including City Council taking up a special use permit for student housing building on JPA, the rezoning of the second phase of Southwood in Albemarle County, and more.* In 2024, I had stories about temporary detention orders, sustainability efforts at the University of Virginia, and Charlottesville City Manager Sam Sanders telling Council he did not want to raise any taxes for the next budget. My memory tells me he didn't but memory is not to be trusted. But I'm not going to look it up now.This is behind the paywall as a thank you note to those who are helping me create an archive of what's been happening these last few years. With your support, I've been able to devote my life to this work. You're allowing me to pay attention to things and bring you stories that hopefully capture the conversations.The last time I did the calculations, about 16.2 percent of the Substack audience pays something. That's over 800 people at this point. I would like that number to increase and one way is to offer more content where I can.And less content in some places, too! For the past month, paid subscribers skip the “shout-outs” to give the newsletter a less cluttered look. The sponsored messages remain, but there's only one display ad per edition.I've been considering writing up photo essays of the changing landscape in Charlottesville. However, adding more work to the pile can sometimes cause me to shut down new ideas.But, I noted in the 2022 edition I wrote about what's now being called “The Adelaide” on JPA. I end this edition sharing some of those pictures and others from a recent walk around Grounds. I'm taking the pictures anyway as I walk around the community and I share them on my personal Facebook.So, as another perk for paid subscribers and to hopefully boost the numbers for these podcast posts, here are some recent photos. For more information on the above project, take a look at cvillepedia. The article is not up to date but a lot of the basics are there. While I helped create it, I have no ownership of the website but spend a lot of time there. Perhaps you might be interested in being an editor?Thoughts on the Verve? Learn more on cvillepedia. This post has bonus content for paid subscribers. Upgrade to get full access which also has the effect of helping me continue this work. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit communityengagement.substack.com/subscribe

His Verve Gallery Affair Unraveled Our Carefully Shared LifeBecome a supporter of this podcast: https://www.spreaker.com/podcast/cheat-stories-official--5689182/support.#CheatingStories #RelationshipDrama #Infidelity #Storytime #Betrayal #cheatstoriesThis episode includes AI-generated content.

Giocare col fuoco: storie, canzoni, poesie di e con Fabrizio Coppola Letture: Fernando Pessoa, Il libro dell'inquietudine (trad. O. Abbati e P. Ceccucci, Newton Compton). Ascolti: Amalia Rodrigues, Madredeus, The Verve, The War on Drugs.

A l'occasion du 55e anniversaire du chanteur Richard Ashcroft, Margaux Lassalle met à l'honneur le troisième album de The Verve : "Urban Hymns". Sorti en septembre 1997, ce disque s'est imposé comme un sommet absolu de la discographie du groupe et un essentiel de la britpop. La chronique revient sur le succès fulgurant de ce projet, porté d'emblée par l'incontournable "Bitter Sweet Symphony", l'une des plus grandes chansons des années 90, célèbre pour ses violons empruntés aux Rolling Stones et la longue bataille juridique qui en a découlé avant que le chanteur n'en récupère les droits. Le disque déploie ensuite toute sa richesse émotionnelle, alternant entre l'intimité acoustique de "Sonnet", l'énergie brute et résolument rock de "The Rolling People", ou encore la bouleversante ballade "The Drugs Don't Work", évoquant la maladie, l'inefficacité des remèdes et la dépendance. Explorant également l'usure des relations avec "Space and Time", l'album brille par sa profondeur. Le segment se referme sur la mise en lumière d'un autre immense succès de ce classique : "Lucky Man". Cet hymne à l'apaisement et au bonheur amoureux a tellement marqué les esprits que Bono, le chanteur de U2, l'a même cité parmi les chansons qu'il aurait rêvé d'écrire.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Sunday Morning, the opening track of the seminal, self-titled VELVET UNDERGROUND AND NICO, written by Lou Reed and John Cale, and produced by Tom Wilson, was originally created for the Teutonic Chanteuse, Nico, but ended up being sung by Lou.The theme of the lyrics: - "paranoia" - credited to a suggestion made by Andy Warhol, and then realized in dreamlike images by Reed, was brought to shimmering life by the last minute addition of the celeste, played by John Cale. 

The guys share a variety of tracks on this week's ride while Hank decides to get a little cocky with the riders and listeners, creating a feud that doesn't yet seem to be settled. Included: Faux Jean; Rodney Crowell; Anouk; Tom Waits; Anouk (again); Leonard Cohan; Larry Grab; Bleachers; Wren; The Verve; OGWS

Your “global” checkout is only as strong as its most local payment method. I'm joined by João Del Valle , CEO of EBANX, to unpack what really happens when a fast-growing merchant tries to launch across emerging markets and discovers that international card acquiring alone is not enough. We get specific about why local payments unlock demand, from PIX in Brazil to pay by bank experiences and domestic card brands like Verve, and why these rails can determine whether you reach the market at all.We also dig into the commercial reality behind expansion: setting up local entities, teams, and infrastructure can take years, while many companies want to go live in 50 to 100 countries in parallel. João explains how EBANX helps global merchants accept alternative payment methods, enable installments, improve authorization rates, and deliver unified reporting and settlement across Latin America, Africa, and Asia. We talk through the verticals where this matters most, including retail marketplaces, streaming and digital services, advertising, and travel, where local installments can be the difference between abandonment and purchase.Then we zoom out to the biggest payments trends reshaping the industry: AI, early moves toward agentic payments, stablecoins for cross-border payments, and blockchain as settlement infrastructure. A major thread is the rapid rise of account-to-account payments, driven by financial inclusion, cost dynamics, and a consumer desire for predictable money movement without surprises.

Moral ist en vogue – genauer gesagt: Moralisieren. Was geschieht da genau, wenn mit deutlicher Verve und Steigerung moralische Begriffe, Konzepte und nicht zuletzt Vorwürfe schnell und scheinbar treffsicher in Anschlag gebracht werden? Moral ist, so Niklas Luhmann, kein eigenständiges gesellschaftliches Funktionssytem. Sie erfüllt aber eine wichtige Alarmierfunktion. Dies erweiternd zeigt Fritz B. Simon, Autor unter anderem des vielgelesenen und -diskutierten Essays Die kommenden Diktaturen, in seinem neuen Essay Moralisieren: Waffe im Kulturkampf, wie Moralisieren 2.0 funktioniert: Den Wissenschaften beispielsweise wird – entgegen deren eigener Funktion und Intention – von manchen nachhaltig unterstellt, moralisch getrieben zu sein. Ihnen wird Moralisieren zugeschrieben, um sie dann wieder scheinbar moralisch stellen und letztlich disqualifizieren zu können. Auch dem Rechtssystem wird ähnliches vorgeworfen. Moralisieren 2.0 als wirkungsvoller Spielzug und als Waffe in der Arena, wo es darum geht, wie wir leben wollen. Wir sprechen mit Fritz B. Simon unter anderem darüber, über die besondere Organisation von Achtung und Missachtung in Kommunikation mit und über Moral sowie über die größeren Kontexte, wie etwa Marktfundamentalismus, in denen diese Kämpfe stattfinden. Viel Spaß im Interview mit Fritz B. Simon bei Carl-Auer Sounds of Science. _____________ Folgt auch den anderen Podcasts von Carl-Auer: autobahnuniversität https://www.carl-auer.de/magazin/autobahnuniversitat Blackout, Bauchweh und kein` Bock https://www.carl-auer.de/magazin/blackout-bauchweh-und-kein-bock Cybernetics of Cybernetics https://www.carl-auer.de/magazin/cybernetics-of-cybernetics Genau Geschaut: https://www.carl-auer.de/magazin/genau-geschaut Frauen führen besser https://www.carl-auer.de/magazin/frauen-fuhren-besser Formen (reloaded) Podcast https://www.carl-auer.de/magazin/formen-reloaded-podcast Heidelberger Systemische Interviews https://www.carl-auer.de/magazin/heidelberger-systemische-interviews Zum Wachstum inspirieren https://www.carl-auer.de/magazin/zum-wachstum-inspirieren Zusammen entscheiden https://www.carl-auer.de/magazin/zusammen-entscheiden-2

In this episode of Lab Rats to Unicorns, John Flavin sits down with Dr. Kiran Musunuru, a cardiologist, geneticist, professor at the University of Pennsylvania, and leading expert in gene editing. Kiran's research spans cardiovascular, metabolic, and rare genetic diseases, with a focus on turning advances in human genetics and CRISPR into therapies that address the underlying causes of disease. He is also a co-founder of Verve Therapeutics and helped lead the development of a personalized gene-editing treatment for infant KJ Muldoon. Kiran traces the path that brought him to gene editing, from growing up with a cardiologist father and pursuing combined medical and scientific training to recognizing the potential of human genetics, stem cells, and eventually CRISPR. He explains how his willingness to adopt new technologies led his lab from early tools like zinc finger nucleases and TALENs to CRISPR, base editing, and prime editing. That progression ultimately opened the possibility of not simply treating symptoms, but making precise changes to DNA that could turn off disease-causing genes or repair genetic mutations at their source. Throughout the conversation, Kiran shares how experiments targeting the cholesterol gene PCSK9 led to the idea of a one-time treatment for cardiovascular disease and ultimately to the creation of Verve Therapeutics. He discusses his unexpected journey into entrepreneurship, Verve's progression into human trials and acquisition by Eli Lilly, and his return to academia to apply the same gene-editing platform to rare diseases. The episode culminates with the remarkable story of KJ, whose personalized base-editing therapy was designed and produced in roughly six months, as well as Kiran's larger vision for transforming one-off treatments into a scalable platform capable of reaching patients around the world.

At most community banks, cybersecurity sits with an IT manager who already owns hardware, software, vendor risk, and board reporting. AI agents are now exploiting the same access control and segmentation gaps the industry has known about for twenty years, and that job has outgrown one desk. Amber Buker, Chief Research Officer at Travillian, sits down with Chris Bedel, Founder, President and CEO of Bedel Security, and Cyrene Wilke, COO of Verve, a Credit Union, to work through what security leadership needs to look like inside a $1 to $10 billion institution, and how to tell whether yours needs a full-time CISO, a fractional partner, or something else.

Disney Cruise Line is returning to New York in 2027, with the Disney Wish sailing seven voyages from the city between September 29 and November 5 to Bermuda, Canada and New England, and one-way to San Juan, alongside maiden Panama Canal calls at Fuerte Amador and Colon. A new study from advertising intelligence company Verve finds that 91 percent of U.S. consumers using AI tools research only one cruise brand, with the average shopper considering 1.12 cruise lines, Royal Caribbean drawing 37.1 percent of branded search activity, and price and value guiding 60 percent of consumers. And Ulyssia Residences, chaired by Frank Binder, has signed a letter of intent worth up to 1.5 billion dollars with China Merchants to build a 323-meter residential yacht carrying 122 residences and 22 guest suites, with a planned 2031 launch.

ⓦ weekly52 Blog Podcast Video & Artworkhttps://weekly52.de/weekly/490⁠⁠ⓦ

Welcome to The Money Trench! This week, Mark is joined by Kat Kennedy and Tim Parry of Big Life. Over 40 years as a management and publishing powerhouse, Big Life has worked with defining acts such as The Verve, Badly Drawn Boy and Kate Nash. The trio discuss the reality of breaking acts in the current industry, how the company has survived for 40 years, expansion plans – and the maverick genius of original Big Life co-founder, Jazz Summers. NEWSLETTER ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for the TMT newsletter - featuring each week's hottest music industry stories. SOUNDON The Money Trench is sponsored by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SoundOn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. TIXEL The Money Trench is sponsored by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tixel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. KEEP UP TO DATE For the latest podcast and music business updates, make sure to follow us on:  Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@the_money_trench⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Money Trench⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Money Trench⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET IN TOUCH If you have any feedback, guest suggestions or general comments? We'd love to hear from you! -⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get in touch here!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thanks to our partners ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SoundOn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tixel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Earth/Percent⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tom A Smith⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Deviate Digital⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fourth Pillar⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sennheiser⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Junkhead Studio⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tape Notes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Executive Producer: Mike Walsh Producer: Tape Notes 

Agradece a este podcast tantas horas de entretenimiento y disfruta de episodios exclusivos como éste. ¡Apóyale en iVoox! Dentro de un disco (Urban Hymns)repleto de grandes canciones, había una que posiblemente se convirtió en tu favorita: Sonnet. Hoy repasamos su historia. Más info: https://bienvenidoalos90.com Espacio patrocinado por: Tricomes, Angel Medano, Felip Palou, Jon Perez Nubla, Dani GO, Fran Cordero Cañas, Jose Manuel Valera, Barullo, Unai Elordui, JulMorGon, David Salamanca Sanz, Jaime Marchica Band, Sr.Jota, Theinvisibleband, jorge, Llorx Miller, Yago Llopis, boldano, estebansantosjuanesbosch@gmail, Vicent Martin, Matias Ruiz Molina, Próxima Estación Okinawa, Rosa Rivas, jvcliment, Jaume Solivelles, Javier Alcalde, jmgomez, Ana Isabel Miguélez Domínguez, Iñigo Albizu, Rachael, Naïa, Jaime Cruz Flórez, DOMINGO SANTABÁRBARA, faeminoandtired, Javi Portas, Belén Vaca, Ana FM, Eduardo Mayordomo Muñoz, Barrax de Pump, pdr_rmn, fernando, QUIROGEA Integrative Osteopath, J. Gutiérrez, Gabriel Vicente, Carlos Conseglieri, Miguel, Isabel Luengo, Franc Puerto, screaming, HugoBR, Vicente DC, Alvaro Gomez Marin, Alvaro Perez, Sergio Serrano, Isranet, Paco Gandia, Crisele, Wasabi Segovia, Dani RM, Fernando Masero, María Garrido, RafaGP, Macu Chaleka, laura, davidgonsan, Juan Carlos Mazas, Bassman Mugre, SrLara, carmenlimbostar, Piri, Miguel Ángel Tinte, Nuria Sonabé, Pere Pasqual, Juanmi, blinddogs, JM MORENTE, Rubio Carbón, LaRubiaProducciones, cesmunsal, Marcos, jocio, Norberto Blanquer Solar, Tolo Sent, Carmen Ventura, Jordi y varias personas anónimas. ✌️Escucha este episodio completo y accede a todo el contenido exclusivo de Bienvenido a los 90. Descubre antes que nadie los nuevos episodios, y participa en la comunidad exclusiva de oyentes en https://go.ivoox.com/sq/32699

Jonathan Frohlinger, CEO of Big Happy, shares why creative remains advertising's biggest competitive advantage. From building high-impact 3D and CGI campaigns to discussing the future of mobile, digital out-of-home, and AI, Jonathan explains how brands can stand out in an increasingly crowded marketplace. Takeaways Jonathan shares his journey from Starcom and Verve to founding Big Happy. Why creative is still the biggest driver of advertising effectiveness. How CGI and 3D advertising help brands stand out and improve recall. Why emotion is processed before logic and what that means for marketers. The role of mobile and digital out-of-home in modern media strategies. Why creative matters more than targeting once the right audience is reached. How AI should enhance creativity instead of replacing it. Why brands should focus on outcomes instead of simply being "AI-powered." Leadership lessons from growing Big Happy over the past seven years. Advice for marketers looking to build successful careers in advertising and technology. Chapters 00:00 Introduction to Jonathan Frohlinger & Big Happy 01:08 Jonathan's journey into advertising and founding Big Happy 03:18 What Big Happy does and its unique value proposition 04:02 Why high-impact creative and CGI capture attention 06:45 The emotional science behind memorable advertising 08:03 Why brands buy on emotion but stay for performance 09:22 Mobile and digital out-of-home as growth channels 10:55 Creative vs. targeting: Which matters more? 12:20 The future of mobile advertising and media investment 15:25 What's next for mobile, DOOH, and ad tech 16:02 AI's impact on creativity and advertising workflows 19:40 AI hype versus real business value 24:20 Scaling Big Happy and building a strong company culture 27:02 Closing thoughts and farewell Learn more about your ad choices. Visit megaphone.fm/adchoices

Some of the best leadership lessons don't come from business books. Throughout history, different cultures have developed wisdom for how we can interact with and lead others. By exploring what different cultures value, we can identify insights into what might help us be better managers today.Dr. Joel A. Davis Brown is an attorney, executive leadership consultant, and author of The Souls of Queer Folk. Drawing on lessons from LGBTQ+ cultural values and decades of leadership consulting, he helps organizations build more inclusive, perceptive, and human-centered leadership practices.In this episode, we explore how the unique values of the LGBTQ+ community offer a powerful blueprint for transformational leadership. We'll discuss how you can integrate these human-centered insights into your own team culture to create a more inclusive and effective workplace.Conversation Topics(00:00) Introduction(02:34)  Why Joel started researching LGBTQ+ culture and leadership(06:19)  How the research worked: 15 values sorted into 9 meta-themes(09:45)  Overview of the meta-themes: justice, authenticity, verve, interconnectedness, creativity, fluidity, resilience, somatic awareness, perceptiveness(12:52)  Authenticity: internal alignment before external behavior(14:57)  Verve: internal exuberance versus charisma(18:12)  Non-binary thinking: rejecting either/or decisions(22:55)  Somatic awareness: what your body tells you about your work(26:57  Two great managers Joel's worked for(33:06)  [EXTENDED EPISODE] Building these values into team culture, not just individual leadership(39:28)  [EXTENDED EPISODE] Perceptiveness: situational awareness and reading the room

Hello and welcome to the show. Today's guests are Parthasarathy Sridhar, Director for Growth, Strategic Accounts, Projects & Procurement, and Kevin Mashford, CEO, of Verve Design. Together, they've helped shape a reputation for delivering projects with a clear commitment to quality, precision, and accountability.What sets Verve Design apart is its unwavering focus on execution—delivering projects *on time, on budget, and with zero defects*. It's a philosophy that goes beyond good design, emphasizing disciplined project management, technical excellence, and a client-first approach that consistently delivers measurable results.Today, we'll explore what it takes to maintain that standard, how Verve has differentiated itself in a competitive market, and the systems and culture that make their approach possible.So without further ado, let's get into it!..Kevin Mashford - ⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠Parthasarathy Sridhar - ⁠⁠⁠⁠Instagram⁠⁠⁠ | ⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠Verve Design - ⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠..To stay updated with our episodes, please follow us on your favorite streaming platform..The aForm Show - ⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠Alan George - ⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠

Bonus Episode setting the scene for all being well a full length episode during our Autumn season is talking about the Midlands Fringe due to start soon is the lovely Charley McDermott.Charley is a Black Country poet published in BCU, Contemporary Literacy Horizon, SHINE, VERVE, Feast Zine and Speak Volumes Festival anthologies. She led the Zepaniah Forest Poetree Trial, has judged several poetry competitions, placed in Grande Slams, and performed headlines across the Midlands.Her freelancinb spans the arts, environment, and manufacturing, which is reflected in her poetry.She is part of AccessAbility Arts, hosts Sandwell Stanzas, and is currently working for Midlands Fringe.https://www.instagram.com/charley_mwc/https://www.linkedin.com/in/cyanthian/More about Midlands Fringe can be found at:https://www.midlandsfringe.co.uk/

This week we watched one of the most disturbing teen movies of the 90s, the Sarah Michelle Gellar vs Ryan Phillippe near-incest classic Cruel Intentions about terrible people being horrible! We watched this on Kanopy using our library card! Tune in next week when July-brary continues with our movie... The Third Man (1949) ----- SATURDAY JULY 11th!!! Come see Matt Lieb do stand up at the Ice House in Pasadena at 8pm. Tickets are here. Jordan will be at San Diego Comic Con Friday and Saturday July 24th and 25th.  Pre-order signed copies of Jordan's new comic book series "The Amazing Venom" here at bit.ly/goofriends Or order signed coplies of Jordan's Predator: Bloodshed series at bit.ly/bigdangfight Emily got some more FlemGems for you at her ETSY Store. Help support this show and unlock bonus content! Become a member at https://maximumfun.org/joinfreewithads

Willkommen zur neuen Ausgabe Chip & Charge, dieses Mal mit dem Rest der Achtelfinales aus Wimbledon. Die untere Hälfte bei den Damen bleibt weiterhin offen. Allerdings konnte Linda Noskova mit ihrem Sieg gegen Madison Keys ein weiteres Ausrufezeichen setzen. Oft unantastbar bei ihrem eigenen Serve, bewegte sie sich mit viel Verve in ihr zweites Grand Slam Viertelfinale. Dort geht es nun gegen Elise Mertens, die auch gegen Marie Bouzkova ihr hohes Leistungsniveau aus den vorherigen Runden halten konnte. Im zweiten Viertelfinale in der unteren Hälfte spielt Jasmine Paolini gegen Marta Kostyuk. Paolini gewann in drei Sätzen gegen Alexandra Eala, hätte die Partie sogar ... Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

Remco Westermann is a Dutch media, gaming, and adtech entrepreneur who serves as the Founder and CEO of Verve Group SE (formerly known as Media and Games Invest (MGI). With over three decades of professional experience, he has spent more than 20 years building, acquiring, and scaling digital mobile media and online entertainment platforms across Europe and North America.Career Highlights & LeadershipVerve Group SE: Westermann established the foundation of the company by acquiring 100% of the distressed German games company gamigo group AG from Axel Springer. Through a highly active M&A strategy—executing over 35 acquisitions across the gaming and digital advertising sectors (including companies like Captify®)—he transformed the business from a gaming publisher into a massive, publicly traded adtech software platform that matches global advertiser demand with publisher ad supply.

On this episode of One Indescribable Podcast…Adam H, Todd the Librarian, and TV Lindy continue their journey through every episode of Everwood by recapping Season 3 Episode 10: Need to Know"Don't tell me you took your slide projector."Thank you for joining us in beautiful Everwood, we can tell we'll get on just fine!Follow the podcast on Twitter @oneCXGpodcast! Find us @pianomanadam1 (Adam), @librariantodd (Todd), and @tvlindy (Lindy)!Follow Whirlwind Podcasts on social media @WhirlwindPods Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning discusses the transcatheter aortic valve replacement (TAVR) heart team potentially losing a member. He explores the current composition of the TAVR heart team, proposed changes, the thoughts of cardiothoracic societies, and future actions regarding this issue. Chapters  00:00 Intro  01:53 TAVR Heart Team  07:48 JANS 1, Base Editing of PCSK9  09:47 JANS 2, High Volume Valve Sparing ARR  12:03 JANS 3, Western Rheumatic Heart Disease  14:05 JANS 4, Non-Intubated Uniportal VATS SL  15:38 Video 1, Miami Method-Bentall  17:02 Video 2, ALCAPA Repair  18:29 Video 3, Robotic Cardiac Podcast  22:17 Dr. Sundt, Mantle Radiation Patients  31:17 Upcoming Events  Additionally, he spoke with Dr. Thoralf Sundt, Chief of the Division of Cardiac Surgery and Director of the Corrigan Minehan Heart Center at Massachusetts General Hospital, Boston, MA, USA, about patients who have undergone mantle radiation. They discuss the challenges these patients face postoperatively, including the mortality rate associated with reoperations. The conversation also highlights the significance of employing a heart team approach for these patients, emphasizing the importance of preoperative planning and the application of TAVR, which is potentially suitable for these patients. Furthermore, they touch upon topics such as mechanical valves, porcelain aorta, and the importance of conducting careful operations on these patients. Joel also highlights recent JANS articles on in vivo base editing of PCSK9 with VERVE-102 for hypercholesterolemia, defining high-volume centers using prospective data for valve-sparing aortic root replacement, insights from the Netherlands Heart Registration on surgical care for rheumatic heart disease patients, and a cohort study on surgical techniques and outcome analysis of non-intubated uniportal VATS sleeve lobectomy. In addition, Joel explores a step-by-step technique for a minimally invasive Bentall procedure via right axillary access, the repair of an anomalous left coronary artery from the pulmonary artery via direct coronary transfer, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Husam Balkhy about multi-spectrum robotic cardiac surgery. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned In Vivo Base Editing of PCSK9 With VERVE-102 for Hypercholesterolemia Valve-Sparing Aortic Root Replacement: Defining High-Volume Centres Using Prospective Data Surgical Care for Rheumatic Heart Disease Patients: Insights From the Netherlands Heart Registration Surgical Techniques and Outcome Analysis of Non-Intubated Uniportal VATS Sleeve Lobectomy: A Cohort Study CTSNet Content Mentioned Minimally Invasive Bentall Procedure via Right Axillary Access: A Step-by-Step Technique Repair of Anomalous Left Coronary Artery From the Pulmonary Artery via Direct Coronary Transfer The Atrium: Multi-Spectrum Robotic Cardiac Surgery Other Items Mentioned Cardiac Reoperations in Patients With Prior Thoracic Radiation: A Single-Center Analysis of Outcomes and Key Lessons CTSNet Innovation Video Competition Career Center CTSNet Events   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Ce 29 juin, Marjorie Hache met à l'honneur les Sex Pistols, James Brown, The Red Hot Chili Peppers, Jimi Hendrix, The Verve, Lana Del Rey, Sum 41, The Troggs, The Hives, Green Day, Alice In Chains, Liam Gallagher, Deep Purple et Stevie Wonder. L'animatrice évoque le 51e anniversaire de la mort tragique de Tim Buckley avec le titre "Move With Me". Jack White donne le coup d'envoi des nouveautés avec "Dollar Bill". Mike D, ex-Beastie Boys, confirme son retour en solo avec "What We Got", tandis que Saint Agnes s'ajoute à la sélection. La primeur de la soirée offre une collaboration détonante : les Américains de The Offspring s'associent aux Allemands d'Electric Callboy sur le survolté "Let The Good Times Roll", mélange inattendu de punk, métalcore et EDM. L'album de la semaine célèbre le retour de Jon Spencer, mythique blues rocker new-yorkais. Son tout nouveau disque, "Songs Of Personal Loss and Protest", se dévoile aujourd'hui à travers l'énergique titre "Knock 'em Out". La reprise du jour convoque deux légendes : David Bowie et Mick Jagger reprennent le tube de la Motown "Dancing In The Street" (Martha and the Vandellas), une relecture bouillonnante enregistrée le 29 juin 1985 au profit du Live Aid. Jack White - Dollar Bill Jimi Hendrix - Fire Tim Buckley - Move With Me James Brown - Living In America Black Strobe - I'm A Man The Verve - The Drugs Don't Work Lana Del Rey - Born To Die Jon Spencer - Knock 'Em Out Sex Pistols - Anarchy In The U.K. Sum 41 - Landmines The Troggs - Wild Thing Mike D - What We Got David Bowie & Mick Jagger - Dancing In The Street Red Hot Chili Peppers - Give It Away Liam Gallagher - Wall Of Glass Social Distortion - Wicked Game Deep Purple - Hush The Hives - Go Right Ahead Saint Agnes - The Ghost Stevie Wonder - Superstition Bloodhound Gang - Mope Electric Callboy - Let The Good Times Roll Feat. The Offspring Green Day - The American Dream Is Killing Me Minor Victories- Scattered Ashes Cream - White Room Alice In Chains - FrogsHébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Tastykakes, Soul Songs and Shining Stars is a rich and passionate record of a life-long obsession with soul music and Rhythm & Blues from music industry stalwart Joe McEwen, legendary A&R man for acts including Elvis Costello, Paul Simon, K.D. Lang, Wilco, Nick Lowe, Built To Spill, Queen Latifah, the Frank Sinatra catalogue, and many others.Tastykakes, Soul Songs and Shining Stars is a labor of love, half a century in the making, for music industry veteran Joe McEwen. A Philadelphia native and legendary A&R executive for Columbia, Sire/Warner Brothers, Verve, and Concord Music Group, McEwen now McEwen gathers a lifetime's worth of encounters, essays, and reveries into one radiant collection-a love letter to the rhythm-and-blues and soul music that shaped him.Its pages are bursting with vivid, compelling, up-front and personal profiles and encounters with a host of important figures: Pops and Mavis Staples, George Clinton, Allen Toussaint, Betty Wright, Michael Jackson, Aretha Franklin, Don Covay, and many more. Alongside these portraits are heartfelt musings spanning the 1960s through the '80s, illuminating the creative processes behind the songs that defined a generation.Interwoven throughout are reflections on basketball, memory, and movement-parallel sources of rhythm, improvisation, and joy. The book culminates in an extended 2024 conversation with esteemed music author and longtime confidant Peter Guralnick (Elvis Presley, Sam Cooke), a fitting finale to a collection that captures the soul of a lifetime in music.Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-unplugged-totally-uncut--994165/support.

Bobby counts down his Top 10 alternative rock songs of all-time and shares the stories, memories, and reasons behind every pick. From R.E.M. and Nirvana to Radiohead, Green Day, Weezer, Pearl Jam, and The Verve, he explains what made each song stand out and why that era of alternative music still hits so hard. Along the way, he talks about seeing the Red Hot Chili Peppers more than 10 times, meeting Weezer on American Idol, and the song he believes changed the music industry forever. Plus, he brings Eddie in to go over the list and get his thoughts! Watch The BobbyCast on Netflix! Follow on Instagram: @TheBobbyCast Follow on TikTok: @TheBobbyCastSee omnystudio.com/listener for privacy information.

This week we talk about LDL, HDL, and cardiovascular issues.We also discuss one-time therapies, statins, and pharmaceutical economics.Recommended Book: Blood by Dr. Jen GunterTranscriptCholesterol is the most common type of what's called a sterol, which is a type of steroid, but also structurally technically an alcohol. But functionally, and classified by scientists, cholesterol is a lipid, which in this case is similar to a fat in all but how the body uses it. Cholesterol is the type of sterol most commonly found in animals—other types are found in plants and fungi—and its function, and this is where it varies from fats, which are used to store energy, is to basically help hold the cell membrane together, and it also serves as an intracellular messenger.Cholesterol is especially prevalent in the brain and spinal cord of animals, but it's found throughout their bodily tissues, as well, and again, it's vital for holding everything together and helping things communicate, in addition to being a precursor for vitamin D, steroid hormones, and bile.You want to have cholesterol, then, as without it you would be dead.Too much cholesterol in the blood, however, can also make you dead, especially when it's bound to what's called low-density lipoprotein, or LDL, as that contributes to cardiovascular disease like heart attacks and aneurysms, which can massively impact one's overall wellness and quality of life, and at extremes lead to the whole system shutting down as a consequence of heart attack, stroke, and the like.A lot of things can contribute to the development of cardiovascular disease, including habits like smoking, genetic predisposition, and the enthusiastic consumption of alcohol and unhealthy foods. But high blood cholesterol, of the LDL variety, is one of the top contributors, as these low-density clusters of lipoprotein can clog the pathways that blood takes throughout our bodies. Other, denser types of lipoproteins, HDLs, can clear it, like a heavier, denser substance pushing through clogs of less-dense materials that are gumming up a pipe, but LDL is at times accumulated as a result of consuming delicious but unhealthy foods, which are hard to avoid, and for some people the only consistently available and affordable foods; and for other people LDL accumulates as a result of their genetic predispositions—two things that are devilishly difficult to change.What I'd like to talk about today is a new type of therapy that may be very good news for people who struggle with the accumulation of LDL, and why this is being seen as very good news more broadly, at the scale of entire nations, as well.—Pharmaceutical company Eli Lilly is testing a new, experimental drug called VERVE-102 which is a one-time infusion that is currently administered over the course of about four hours, and once completed, it turns off a gene called PCSK9, which is responsible for making a protein that regulates cholesterol levels in humans.As I said, this drug is still being tested, so these are early results. But in a study of 35 people with high cholesterol levels, high levels of LDL or LDL-C, which is short for lipoprotein cholesterol, they found that this infusion, which again, is a one-time treatment, so get it once and then theoretically at least you never have to get anything done ever again, it reduced those LDL and LDL-C levels by as much as 62%, and that reduction was maintained a year and a half after the infusion; that's how far out they're retested so far, and the hope is that each retest will continue to show the same.On the strength of those very promising results, a Phase 2 study has been planned by the end of 2026, and the US Food and Drug Administration, the FDA, previously fast-tracked this existing study, because of the promise and potential this drug already demonstrated in early studies; all of which is considered to be very significant progress and possibility.To understand that significance, though, it's useful to know some health stats. And I'm going to focus on the US here, as that's where this drug is being developed, but many wealthy countries have similar stats, at least in terms of cardiovascular disease struggles.As of 2024, which is the last year we had good, cohesive data on this in the US, it was estimated that about 11-12% of the US adult population has high cholesterol levels. This typically doesn't come with any symptoms, but it can contribute a higher risk for all those cardiovascular diseases, including heart attack and stroke. A further 86 million US adults have borderline or elevated cholesterol levels, which can easily tip higher, but also, even in that existing, elevated state, contribute to negative cardiovascular outcomes.There are treatments for high cholesterol, the most common of category of which are called statins, which reduce the production of LDL by inhibiting an enzyme that produces cholesterol in the body.Unfortunately, these drugs do come with some usually minor side effects, which can cause patients to stop using them, and they have to be taken daily, ideally at the same time each day. That necessity for consistency leads to a lot of incorrect or incomplete usage, which reduces the effectiveness of these drugs. But it's also estimated that only about 54.5% of US adults who would benefit from statins are currently taking one—so that's people who could benefit and who have it prescribed, and then within that number are all the people who are taking this drug incorrectly or incompletely, reducing the effectiveness. So a relatively small number of people who should probably be on these things are getting the full benefit they offer because of the nature of the drug.And that's not great, because in the US alone, heart disease is the leading cause of death for pretty much every adult demographic; men, women, people of most racial and ethnic and economic groups, you name it, heart disease is the biggest threat to their lives.One US citizen dies every 34 seconds of some kind of cardiovascular condition, and as of 2023, 1 in every 3 deaths in the US was caused by the same, adding up to just over 919,000 people that year.Between 2021 and 2022, alone, the cost of services and medications related to heart disease added up to more than $168 billion; again, that's just in that period, and just in the US.And once more, these are ailments that are caused or heavily influenced by high levels of cholesterol, which are themselves amplified by common lifestyle choices, environmental factors that are hard for many people to avoid, and just by raw, dumb luck because of genetics.This treatment category, then, is being seen as a pretty big deal because a one-time infusion means those who receive it don't have to remember to take a pill every day at the same time, and won't experience those statin-based side-effects.It also means that people who are currently costing the medical system a bunch of money each year, because they need treatments for all the issues they suffer as a result of high cholesterol, will suddenly cost the system a lot less money, for treatments and medications. Not for nothing, their health and quality of life will likely improve as well. So in addition to having better, healthier outcomes personally, their cost to healthcare systems will drop.Eli Lilly's drug isn't the only one currently working its way through clinical trials, either.Amgen is working on a similar treatment, and Novartis and Ionis Pharmaceuticals have drugs that are even further along in the process, their medicines that cut heart attacks, strokes, and cardiovascular deaths could be approved by the FDA as soon as next year.There are a lot of caveats worth noting here, including that the science is still out as to whether this approach, silencing proteins that lead to the creation of more LDL and a similar substance called Lp(a)—which is more dangerous because it's stickier and thus more likely to get stuck in important blood pathways, and it's also more likely to be caused by genetics than lifestyle—the word is still out on whether reducing these things in the body actually reduces hearth attacks and stroke.Some people have had this particular risk variable dramatically reduced, but have still suffered from cardiovascular events, which raises the question of whether this path is the right one to take in trying to reduce this category of health issues; the correlation between LDL and heart attacks and strokes might not be a clear-cut as long assumed.There's also the issue of price. Drug-makers are economically incentivized to sell treatments over cures, because that means they can continue selling their product over time, potentially for the life of the patient, and a cure, in contrast, is a one-time hit that in theory should alleviate the need for future treatment.There's a chance, then, that the drug-makers will decide they need to make these one-hit treatments really, really expensive in order to make their R&D dollars back and to make the kinds of profits their investors expect from them. That could then reduce the potential audience for these treatments, even if they are effective, and could further slow their deployment and future research in this space.If these trials continue to go well, though, there's a good chance that this combination of similar but distinct treatment types will provide a more sustainable alternative to current options, and that, like the recent bogglingly rapid and widespread deployment of GLP-1 treatments for all sorts of issues, could lead to a new paradigm in this facet of the medical world.Show Noteshttps://en.wikipedia.org/wiki/Cholesterolhttps://en.wikipedia.org/wiki/Cardiovascular_diseasehttps://en.wikipedia.org/wiki/High_cholesterolhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10982736/https://www.cdc.gov/heart-disease/data-research/facts-stats/index.htmlhttps://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1https://www.ama-assn.org/public-health/chronic-diseases/what-doctors-want-patients-know-about-high-cholesterolhttps://en.wikipedia.org/wiki/Statinhttps://pubmed.ncbi.nlm.nih.gov/42187087/https://abcnews.com/GMA/Wellness/new-drug-game-changer-people-high-cholesterol/story This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

I caught up with Kurt for the Art of Longevity at his home in the leafy, trail-threaded neighbourhood of Mount Airy ("there's like one coffee shop, one grocery store kind of thing"), where, if you're a local dad with a creative streak and a guilty conscience, you too might one day hand him something strange and wonderful. Philadelphia's Been Good To Me is Kurt's tenth album, and it arrives draped in the city's 250th anniversary of independence, although Kurt would like you to know that the Philly references preceded any civic occasion. "I've really been calling out Philly the whole time," he says, without particular urgency. "I called myself Philly's constant hitmaker, you know, early on, so all signs were pointing to this for natural reasons."The phrase natural reasons crops up around Kurt Vile the way it tends to around artists who have figured something out that they couldn't quite explain if you put them on the spot. His producer Rob Schnaff asked him early in the sessions: is this your Philly record? Kurt had already sung Philadelphia into three different songs by that point. Sometimes an album tells you what it is before you know it. The record was made in part, as increasingly his records are, at home. His home studio has become the full circle he didn't quite plan to draw but which now makes complete sense: back in his twenties he was recording DIY bedroom tapes; now he's in his forties doing essentially the same thing, except for a major label (Verve) and in high fidelity. The method hasn't changed but the context has - the proverbial “slacker” has become an all out star of considerable standing in the global indie rock scene. The Art of Longevity Season 13 is powered by Bang & Olufsen. The book of the podcast, Riding the Rollercoaster, is now available. Support the showGet more related content at: https://www.songsommelier.com/

Send us Fan MailWelcome to Guess the Year! This is an interactive, competitive podcast series where you will be able to play along and compete against your fellow listeners. Here is how the scoring works:10 points: Get the year dead on!7 points: 1-2 years off4 points: 3-5 years off1 point: 6-10 years offGuesses can be emailed to drandrewmay@gmail.com or texted using the link at the top of the show notes (please leave your name).I will read your scores out before the next episode, along with the scores of your fellow listeners! Please email your guesses to Andrew no later than 12pm EST on the day the next episode posts if you want them read out on the episode (e.g., if an episode releases on Monday, then I need your guesses by 12pm EST on Wednesday; if an episode releases on Friday, then I need your guesses by 12 pm EST on Monday). Note: If you don't get your scores in on time, they will still be added to the overall scores I am keeping. So they will count for the final scores - in other words, you can catch up if you get behind, you just won't have your scores read out on the released episode. All I need is your guesses (e.g., Song 1 - 19xx, Song 2 - 20xx, Song 3 - 19xx, etc.). Please be honest with your guesses! Best of luck!!The answers to today's ten songs can be found below. If you are playing along, don't scroll down until you have made your guesses. .....Have you made your guesses yet? If so, you can scroll down and look at the answers......Okay, answers coming. Don't peek if you haven't made your guesses yet!......Intro song: Keep the Faith by Bon Jovi (1992)Song 1: Somebody That I Used to Know by Gotye (2011)Song 2: Bittersweet Symphony by The Verve (1997)Song 3: Rhinestone Cowboy by Glen Campbell (1975)Song 4: You Can't Hurry Love by The Supremes (1966)Song 5: One More Time by Daft Punk (2000)Song 6: Purple Rain by Prince & the Revolution (1984)Song 7: Groove Is In the Heart by Deee-Lite (1990)Song 8: One, Two Step by Ciara (feat. Missy Elliott) (2004)Song 9: My Heart Will Go On by Celine Dion (1997)Song 10: Body Like a Back Road by Sam Hunt (2017)

375: Verve Market may be the next big thing when it comes to grocery shopping for those with IBS, food sensitivities, special diets, or just for those trying to avoid stevia, natural flavors, and just want to eat healthier overall. Imagine a grocery store curated entirely for you and your family specifically catering to your needs, and everything in that store you can choose! That's what Verve Market is doing when it comes to grocery shopping. I have the founder, Andres, on with me today as he shares his own experience with IBS and why he created Verve in the first place....it was out of his own desire and necessity to make grocery shopping less stressful, more enjoyable, and incredibly quick and easy without needing to drive anywhere! And the best part is that there's no membership or monthly fee!  With Verve Market, you can curate and cut out basically anything that doesn't serve you and your family's diet, even down to the spices in foods, so you can feel confident in what you are purchasing without taking 2 hours at the store, and you may even discover new items you thought never existed that you can still enjoy!  The founder has also requested those listening to give him feedback. So once you browse their website, please email him at hi@vervemarket.com with any suggestions you may have. This is all about community and customer experience and since Verve Market is brand new, they want to make sure the customer is getting what they want and are always looking to improve! So again, email them at : hi@vervemarket.com with your feedback and suggestions. Topics Discussed: → What Is Verve Market? → How Verve Market Works → Why Grocery Shopping Is So Difficult With IBS → Food Sensitivities, Allergies & Personalized Shopping → How Verve Differs From Thrive Market & Other Platforms → Hidden Ingredients, Natural Flavors & Label Reading → Making Healthy Grocery Shopping Easier For Families → The Future Of Personalized Nutrition & Grocery Shopping Get $60 off across your first three deliveries Go to: vervemarket.com/digest As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Fatty15 | For 15% off the starter kit go to https://fatty15.com/digest Timestamps: → 00:00:00 - Introduction  → 00:02:40 - Fatty15 Sponsor Message → 00:04:38 - Meet Andres + The Vision Behind Verve → 00:05:35 - How IBS Inspired Verve Market → 00:08:15 - Why Grocery Shopping Feels Like A Full-Time Job → 00:10:00 - How Verve Personalizes Your Grocery Experience → 00:12:45 - Hidden Ingredients, Natural Flavors & Label Reading → 00:14:50 - The Technology Behind Verve → 00:16:40 - How Verve Works For Families With Different Dietary Needs → 00:19:00 - Discovering Foods You Thought You Couldn't Eat → 00:20:45 - Customizing Foods, Ingredients & Sweeteners → 00:21:50 - Delivery, Pickup & No Membership Fees → 00:23:25 - How Verve Makes Money → 00:24:35 - What Makes Verve Different From Thrive Market → 00:27:30 - Is Online Grocery Shopping Better? → 00:28:15 - Grocery Shopping Without The Stress → 00:30:50 - Helping Parents Navigate Food Choices With Kids → 00:32:40 - The Challenges Of Healthy Grocery Shopping → 00:33:00 - Feedback From Customers & Healthcare Professionals → 00:34:25 - The Future Of Verve Market → 00:35:15 - Final Thoughts + Special OfferFurther Listening: →https://podcasts.apple.com/us/podcast/the-best-worst-foods-for-ibs-bok/id1637478937?i=1000619110969 Check Out Verve Market: → Verve Market | https://www.instagram.com/vervemarketco/Check Out Bethany: → Bethany's Instagram: ⁠@lilsipper⁠ → ⁠YouTube⁠ → ⁠Bethany's Website⁠ → ⁠Discounts & My Favorite Products⁠ → ⁠My Digestive Support Protein Powder⁠ → ⁠Gut Reset Book ⁠ → ⁠Get my Newsletters⁠ (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Joel Kahn dives into a groundbreaking Phase 1 trial of Verve 102, a one-time intravenous gene-editing treatment that silences the PCSK9 gene to produce lasting LDL cholesterol reduction. Among 35 participants, the high-dose group saw LDL drop by 62% with mostly mild side effects — promising results, though Phase 2 and 3 trials and 15 years of follow-up still lie ahead. Also covered: updated colorectal cancer screening guidelines now starting at age 45, healthy lifestyle habits cutting mortality risk in cancer survivors by one-third, real-world weight regain data after stopping GLP-1 medications, why your B12 "normal" range may be too low, a blood test that may predict Alzheimer's years in advance, and a longevity preparedness tool from MIT AgeLab. Sponsored by Igennus — visit igennus.com/drkahn for 20% off.

Chief Medical Officer of Northwestern Medicine's Northwest region of hospitals Dr. Irfan Hafiz joins Bob Sirott to talk about the effects consuming an abundance of protein can have on our bodies, details surrounding a new cholesterol drug called VERVE-102, and how movement is king. He also discusses the latest research surrounding Ozempic which shows there […]

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Orforglipron for maintenance of body weight reduction  - Nature Medicine2026. Discussion by:Guest:Joe Gonella, MD Resident - Abington Family Medicine Residency Program Jefferson Health2. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN) Lancet 2026.  Discussion by: Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Survival and Recurrence with GLP-1 Receptor Agonists in Breast Cancer" – JAMA Network Open Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.   NEJM 2026 Discussion by:Guest:Alex Sauer, MD Resident - Abington Family Medicine Residency ProgramJefferson HealthMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Tim Conway Jr Show Hour 4 (5.29) Conway kicks off the hour with a look at two promising new cholesterol treatments, enlicitide and VERVE-102, both aiming to help lower LDL “bad” cholesterol — but in completely different ways. One sounds like the future of medicine, and the other sounds like Conway is ready to gamble on it like a casino bet. Then the crew dives into the viral Trader Joe’s Sweet & Sour Gummy Worms story. These innocent-looking candies are loaded with fiber, and because the bag doesn’t exactly scream “high fiber warning,” some shoppers are eating way too many and ending up with stomach rumbling, gas, and a surprise bathroom emergency. The ultimate buzzkill candy. Later, Conway tells his Egg McMuffin story after going 35 years without one, explains how he managed to annoy a pharmacist at CVS, and breaks down the chaos of picking up everyone’s Starbucks drinks. The hour wraps with one of the strangest side hustle stories yet: a 23-year-old creator making serious money selling videos of herself farting. Forget Etsy, rideshare, and vintage clothes — this is the new economy, and Conway has questions. cholesterol treatment, LDL cholesterol, VERVE-102, enlicitide, Trader Joe’s gummies, Sweet & Sour Gummy Worms, high fiber candy, bathroom emergency, Egg McMuffin, CVS pharmacy, Starbucks order, weird side hustle, fart videos, viral story, funny podcast, Conway Show See omnystudio.com/listener for privacy information.

A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in cardiac amyloidosis, and a lipid guideline rebuttal are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Permanent Lipid Lowering therapy Verve 102 Therapy for FH https://www.nejm.org/doi/full/10.1056/NEJMoa2601283 II Vesalius Substudy on PCSK9i Use in Patients With Previous PCI VESALIUS Subgroup Analysis https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.080616 VESALIUS Study - NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2514428 III Tirzepatide looking to be best again SURPASS-EARLY Trial https://www.acpjournals.org/doi/10.7326/ANNALS-25-05602 SURMOUNT-5 Trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2416394 IV Arrhythmias in Cardiac Amyloidosis Loop Recorders Reveal Arrhythmias in Cardiac Amyloidosis https://www.medscape.com/viewarticle/loop-recorders-reveal-arrhythmias-cardiac-amyloidosis-2026a1000gq9 EXCALIBUR Study https://www.jacc.org/doi/10.1016/j.jacc.2026.04.030 V Lipid Guidelines ·       In Defense of the 2026 Dyslipidemia Guideline https://www.medscape.com/viewarticle/defense-2026-dyslipidemia-guideline-2026a1000hd0 Lipid Guidelines: Four Major Concerns https://www.medscape.com/viewarticle/lipid-guidelines-four-major-concerns-2026a1000fim You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Andrew, Ben, and Tom discuss the reported two-phase US-Iran deal to reopen the Strait of Hormuz and dispose of enriched uranium, market reactions with oil dropping to the low $90s and the 10-year falling to 4.50%, Kevin Warsh's first comments as Fed Chair signaling reform, the WSJ piece on the vanishing equity risk premium, and Eli Lilly's VERVE-102 one-shot gene editing therapy showing up to 62% LDL cholesterol reduction in early trials as a potential challenger to Amgen's Repatha.Join our live YouTube stream Monday through Friday at 8:30 AM EST:http://www.youtube.com/@TheMorningMarketBriefingPlease see disclosures:https://www.narwhal.com/disclosure

Featuring new releases from pianist Jon Batiste, Nigerian chanteuse Douyé, and modern master Judith Berkson; brilliant archive drops of Roy Hargrove's quintet and Kenny Barron's trio; the soulful mastery of Jonah Smith; and a slappin' remix of Nina Simone by legendary DJ Desiree on Verve.

AI in the salon industry is moving fast, and most salon owners genuinely don't know where to start. My guest this week is Frank Westerbeke, co-owner of Gadabout and VerVe, a multi-generational salon group with six locations and nearly 300 staff in Tucson, Arizona. Frank's been using AI across his business for years, not just for Instagram captions, but for people management, financial analysis, team communication, and the client experience.What you'll hear in this conversation will make AI feel far less intimidating. Frank is not a tech person. He's a salon person. And the way he talks about AI, as a bridge, not a replacement, will shift how you think about it. IN THIS EPISODE:[00:00] Introduction: AI in the salon industry and what's at stake[01:04] Meet Frank Westerbeke, co-owner of Gadabout and VerVe[02:09] Running 6 salons and 300 staff, Frank's role as the human connector[04:14] How Frank uses AI voice on the drive to a salon before a tough conversation[06:44] Why Frank gave his managers permission to use AI and what changed[10:23] Turning managers into leaders with AI as the bridge[18:07] Why Frank's marketing team uses AI to enhance creativity, not replace it[22:45] The client experience: where AI helps and where the human must stay[27:00] Using AI to free up human connection in the salon[41:42] Frank's advice for salon owners who haven't started yetRATINGS + REVIEWS

This week, hosts Jim DeRogatis and Greg Kot talk with biographer Will Hermes about his book on Lou Reed, as well as Lou's music, persona, legacy and more.Join our Facebook Group: https://bit.ly/3sivr9TBecome a member on Patreon: https://bit.ly/3slWZvcSign up for our newsletter: https://bit.ly/3eEvRnGMake a donation via PayPal: https://bit.ly/3dmt9lUSend us a Voice Memo: Desktop: bit.ly/2RyD5Ah Mobile: sayhi.chat/soundops Featured Songs:Lou Reed, "Walk on the Wild Side," Transformer, RCA, 1972The Beatles, "With A Little Help From My Friends," Sgt. Pepper's Lonely Hearts Club Band, Parlophone, 1967The Velvet Underground and Nico, "Sunday Morning," The Velvet Underground & Nico, Verve, 1967The Velvet Underground and Nico, "Heroin," The Velvet Underground & Nico, Verve, 1967The Velvet Underground, "Pale Blue Eyes," The Velvet Underground, MGM, 1969Lou Reed, "Coney Island Baby," Coney Island Baby, RCA, 1975The Velvet Underground, "Some Kinda Love," The Velvet Underground, MGM, 1969Lou Reed, "How Do You Think It Feels," Berlin, RCA, 1973Lou Reed, "Perfect Day," Transformer, RCA, 1972The Velvet Underground, "Sweet Jane," Loaded, Cotillion, 1970The Velvet Underground and Nico, "I'll Be Your Mirror," The Velvet Underground & Nico, Verve, 1967The Velvet Underground, "Candy Says," The Velvet Underground, MGM, 1969Pixies, "Here Comes Your Man," Doolittle, 4AD and Elektra, 1989See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's podcast episode, we discuss what's broken in how we evaluate media, the problem with reach, and what “quality inventory” actually means. Join Senior Director of Podcasts and host Marcus Johnson, along with Analyst Arielle Feger and David Simon, Chief Revenue Officer of Verve and President of Verve Marketplace. Listen anywhere, or watch on YouTube or Spotify.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-media-quality-measurement-gap-between-seeing-knowing-behind-numbers © 2026 EMARKETER   Illuminate. Connect. Activate.   Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale.   Learn more  

In today's podcast episode, we discuss what's broken in how we evaluate media, the problem with reach, and what “quality inventory” actually means. Join Senior Director of Podcasts and host Marcus Johnson, along with Analyst Arielle Feger and David Simon, Chief Revenue Officer of Verve and President of Verve Marketplace. Listen anywhere, or watch on YouTube or Spotify.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-media-quality-measurement-gap-between-seeing-knowing-behind-numbers © 2026 EMARKETER   Illuminate. Connect. Activate.   Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale.   Learn more  

On today's podcast episode, we discuss the stats that best explain how sports betting is taking over America, Americans' sentiment toward how betting impacts sports and society, and how brands might be able to get involved in the betting space responsibly. Join Senior Director of Podcasts and host Marcus Johnson, along with Principal Forecasting Writer Ethan Cramer-Flood and Senior Forecasting Analyst Zach Goldner. Listen everywhere, or watch on YouTube and Spotify.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-america-love-hate-relationship-with-sports-betting-game © 2026 EMARKETER   Illuminate. Connect. Activate. Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale. Learn more at https://verve.com/?utm_campaign=40660637-2026_emarketer&utm_source=emarketer&utm_medium=podcast  

On today's podcast episode, we discuss the stats that best explain how sports betting is taking over America, Americans' sentiment toward how betting impacts sports and society, and how brands might be able to get involved in the betting space responsibly. Join Senior Director of Podcasts and host Marcus Johnson, along with Principal Forecasting Writer Ethan Cramer-Flood and Senior Forecasting Analyst Zach Goldner. Listen everywhere, or watch on YouTube and Spotify.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-america-love-hate-relationship-with-sports-betting-game © 2026 EMARKETER   Illuminate. Connect. Activate. Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale. Learn more at https://verve.com/?utm_campaign=40660637-2026_emarketer&utm_source=emarketer&utm_medium=podcast  

On today's podcast episode, we discuss how this kind of energy-driven inflation shows up differently for retailers compared to what we saw with tariffs last year, the ripple effects that are being underestimated, and which of these changes we think are temporary versus those that will actually reshape how people shop. Listen to the discussion with Vice President of Content and host Suzy Davidkhanian, Principal Analyst Zak Stambor, and Analyst Rachel Wolff.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-how-war-impacting-american-consumers-wallets-reimagining-retail © 2026 EMARKETER   Illuminate. Connect. Activate. Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale. Learn more at https://verve.com/?utm_campaign=40660637-2026_emarketer&utm_source=emarketer&utm_medium=podcast

David Boxerbaum built his career the hard way, with no connections, no shortcuts, and a relentless belief that great stories still change everything.  He first fell in love with making movies as a young kid growing up in the Bay Area, camera in hand, directing his friends before he even knew what an agent was. After attending New York University, he realized the there was real power in understanding the business behind making movies. So he mailed his resume across town, worked his way through some of the most iconic agencies in the business, and quietly became one of the most prolific spec script sellers in Hollywood. By 26, he was named one of The Hollywood Reporter's Next Generation 35 Under 35 — one of the youngest agents ever to earn that recognition. Today he's a partner at Verve, representing top writers, directors, and showrunners, and is widely credited with helping open the door for the short story market. Join us as we get into what it actually means to believe in your clients, how he generates heat in a bidding war, and why he's optimistic about the future Hollywood. AOP SUBSTACK

In today's podcast episode, we discuss: What if Meta keeps losing all these lawsuits? What if Meta bought Roku? What if Amazon's new smartphone is a hit?   Subscribe to EMARKETER's newsletters. Go to https://www.emarketer.com/newsletters   Follow us on Instagram at: https://www.instagram.com/emarketer/   For sponsorship opportunities, contact us: advertising@emarketer.com   For more information, visit: https://www.emarketer.com/advertise/   Have questions or just want to say hi? Drop us a line at podcast@emarketer.com    For a transcript of this episode, click here: https://www.emarketer.com/content/podcast-what-if-meta-bought-roku-amazon-s-new-smartphone-hit-behind-numbers   © 2026 EMARKETER Made Possible by Illuminate. Connect. Activate.​ Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale. Learn more

In today's podcast episode, we discuss what if Apple delivers on its vision of Apple Intelligence? What if Abercrombie evolves beyond retail into a lifestyle brand? What if Google starts paying for the content its AI uses?   Join Senior Director of Podcasts and host Marcus Johnson, along with Vice President of Content Suzy Davidkhanian, and Principal Analysts Nate Elliott and Yory Wurmser. Listen anywhere, or watch on YouTube or Spotify.   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-what-if-abercrombie-was-lifestyle-google-s-ai-paid-content-behind-numbers © 2026 EMARKETER   Made possible by ​Illuminate. Connect. Activate.​ Verve's global omnichannel advertising platform redefines what's possible beyond walled gardens. Verve illuminates, connects, and activates high-fidelity signals that drive outcomes for brands, agencies, and publishers at scale. Learn more

Melissa Auf der Maur is a musician and bass player best known for bands like Hole and the Smashing Pumpkins. Her new memoir, Even the Good Girls Will Cry, is out next week. We chat with Melissa from her home in upstate New York about the new Apple laptop, Montreal vibes, Grimes and Elon, channeling the gods on stage, shooting a roll of film a day in the '90s, Courtney writing “slut” on her stomach, the time MTV asked her to take The Verve to Tom & Jerry's, when musicians make their best work at their most fucked-up, Canadian ayahuasca retreats, owning Bo Burnham on vinyl, and gently prodding around a Hole reunion one day, and getting back in the studio with Courtney. instagram.com/xmadmx twitter.com/donetodeath twitter.com/themjeans howlonggone.com Learn more about your ad choices. Visit megaphone.fm/adchoices